BSE filing, NSE: INDUSINDBK. Summary written from the filing by ALFA Finder's alert engine.
IndusInd Bank Ltd: key numbers
- Share price
- ₹851.00
- Market cap
- ₹66,305 Cr
- Revenue (annual)
- ₹46,251 Cr
- Net profit (annual)
- ₹889.3 Cr
- P/E (TTM)
- 22.1×Sector 19.7×
- Promoter holding
- 15.82%+0.00% QoQ
- FII holding
- 30.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from IndusInd Bank Ltd
All →IndusInd Bank Results Update
IndusInd Bank's Q2 FY27 press release reports net profit of ₹1,242 crore versus a prior-year loss. Gross NPA improved to 2.73% from 3.60%.
IndusInd Bank Investor Presentation: Key Takeaways
Q2FY27 PAT ₹1,242cr (+20% QoQ) and operating profit ₹2,874cr (+40% YoY), driven by loan growth and better asset quality. NIM fell to 3.23% from 3.57% QoQ. GNPA 2.73%, CRAR 16.59%.
IndusInd Bank Management Change
IndusInd Bank appointed Ms. Priyanka Sinha as Non-Executive Independent Director for four years from 23 Oct 2026, subject to shareholder approval. The filing is a Regulation 30 disclosure with her profile attached.
IndusInd Bank Q2 FY27 Results: Turns Profitable, Net Profit ₹1,242 Cr
IndusInd Bank Ltd reported revenue from operations of ₹11,796 Cr (+1.6% YoY) and net profit of ₹1,242 Cr for Q2 FY27.
- Key figure
- Net profit ₹1,242 Cr
IndusInd Bank Employee Stock Options
IndusInd Bank's Compensation Committee approved 1,00,000 stock options to 11 employees under its ESOP scheme. Grant price is Rs. 849.55 with 3-year vesting.
IndusInd Bank Other Announcement
The company has filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI regulatory requirements.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date